The Kidney Cancer Drugs market is estimated to be valued at US$ 6.2 Bn in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Kidney cancer, also known as renal cell carcinoma, is a type of cancer that starts in the renal cells (kidney tubule cells). It is the most common type of kidney cancer in adults. ... Read more
